Expert Perspectives on Novel Drug Delivery Systems in the Management of Pediatric ADHD

Video

Jeffrey L. Alvaro, M.D., introduces an upcoming panel discussion surrounding the clinical implications of novel drug delivery systems in the management of Pediatric ADHD, utilizing 3 patient cases.

Recent Videos
Peter S. Jensen, MD
Rakesh Jain, MD, MPH
Rakesh Jain, MD, MPH
Perry Roy, MD
Perry Roy, MD | Image Credit: Carolina Attention Specialists
Related Content
Pediatric FDA, clinical trial, and interview recap from Q1 2025 | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.

Q1 2025: A recap of the top headlines and interviews

Joshua Fitch, Senior Editor ;Morgan Ebert, Managing Editor
April 3rd 2025
Article

View our Q1 2025 recap of standout pediatric news from FDA regulatory updates, clinical trial results, and expert commentary.

ADHD Medications: A Look at Their Safety Profile

ADHD Medications: A Look at Their Safety Profile

Joan Daughton, MD
October 17th 2012
Podcast

Each year in this country, physicians prescribe medications to treat ADHD in nearly 3 million children. The safety of these agents has been the subject of some debate.

ADHD with ASD and without it: Should they be treated differently? | Image credit: Contemporary Pediatrics

ADHD with ASD and without it: Should they be treated differently?

Marian Freedman;Jon Matthew Farber, MD
January 29th 2025
Article

"My takeaway is that if medicine is needed, stimulants will be my first choice in this age group, regardless of whether the ADHD coexists with ASD."

Background on digital therapeutics and what they can do for mental health | Image Credit: © Syda Productions - © Syda Productions - stock.adobe.com.

Digital therapeutics and what they can do for mental health

Joshua Fitch, Senior Editor
August 8th 2024
Article

Digital therapeutics help kids build emotional regulation and coping skills, supporting pediatric care while waiting for specialized mental health services.

Image Credit: © Artur - © Artur - stock.adobe.com.

Weekly review: ADHD treatment FDA approval, peanut consumption and adolescent tolerance, and more

Joshua Fitch, Senior Editor
June 3rd 2024
Article

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

FDA approves clonidine hydrochloride to treat ADHD in patients 6 years and up | Image Credit: © Calin - © Calin - stock.adobe.com.

FDA approves clonidine hydrochloride to treat ADHD in patients 6 years and up

Joshua Fitch, Senior Editor
May 29th 2024
Article

The once daily extended-release oral suspension with nighttime dosing is approved to treat ADHD as a monotherapy or as an adjunctive therapy to approved CNS stimulant medications.

© 2025 MJH Life Sciences

All rights reserved.